Is It Too Late To Consider AbbVie (ABBV) After The Recent Share Price Pullback
- With AbbVie at around US$208 per share, this article looks at what the current price might imply and whether the stock may still offer value or if much of the upside has already been realized.
- The stock has pulled back recently, with a 1.5% decline over 7 days, a 5.9% decline over 30 days, and a 9.1% decline year to date, following a 25.4% return over 1 year and 126.9% over 5 years.
- Recent headlines have focused on AbbVie as a large pharmaceutical company, including ongoing attention on its established portfolio and pipeline, as well as its role in broader sector discussions. These themes help frame how investors may think about future cash flows, risk, and what might be a fair price to pay today.
- Right now AbbVie has a value score of
Source link
